In the second step, we investigated the upregulated gene (COL3A1) and downregulated gene (GUCA2A) in the tumor and normal samples expression profile in CRC patients using RNA-Seq data and real-time PCR validation. This evidence concerns the gene GUCA2A and neoplasm.